Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

PROCEPT BioRobotics (PRCT) Shares Outstanding (Weighted Average) (2020 - 2026)

PROCEPT BioRobotics has reported Shares Outstanding (Weighted Average) over the past 7 years, most recently at $56.5 million for Q1 2026.

  • Quarterly Shares Outstanding (Weighted Average) rose 2.9% to $56.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $56.5 million through Mar 2026, up 2.9% year-over-year, with the annual reading at $55.5 million for FY2025, 6.56% up from the prior year.
  • Shares Outstanding (Weighted Average) was $56.5 million for Q1 2026 at PROCEPT BioRobotics, up from $55.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $56.5 million in Q1 2026 and troughed at $43.9 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $51.0 million (2024), against an average of $49.8 million.
  • Year-over-year, Shares Outstanding (Weighted Average) soared 807.97% in 2022 and then grew 1.58% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $44.4 million in 2022, then increased by 6.43% to $47.3 million in 2023, then grew by 10.31% to $52.1 million in 2024, then grew by 6.56% to $55.5 million in 2025, then rose by 1.74% to $56.5 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Shares Outstanding (Weighted Average) are $56.5 million (Q1 2026), $55.5 million (Q4 2025), and $55.4 million (Q3 2025).